Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer

NCT00190710

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States
View Trial Details
Completed

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

NCT00081315

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Cedars Sanai Los Angeles, California, United States
  • Radiation Oncology Center Sacramento, California, United States
  • The Center for Cancer Care Torrington, Connecticut, United States
  • Florida Wellcare Alliance Inverness, Florida, United States
View all 24 locations
View Trial Details
Completed

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent

NCT00264433

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +40 more
Locations
  • Florida Cancer Specialist Fort Myers, Florida, United States
  • Lineberger Comprensive Cancer Center Chapel Hill, North Carolina, United States
  • Duke Comprehensive Cancer Centre Durham, North Carolina, United States
  • Chattanooga Oncology and Hematology Associates Chattanooga, Tennessee, United States
View Trial Details
Completed

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

NCT00490659

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lublin, Poland
View Trial Details
Completed

Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy

NCT00489983

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milan, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, United Kingdom
View Trial Details
Completed

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

NCT00034827

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +24 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Blendora, California, United States
  • Pfizer Investigational Site Glendale, California, United States
View all 30 locations
View Trial Details

Related conditions